The C2 domain of calpain 5 contributes to enzyme activation and membrane localization.
暂无分享,去创建一个
J. Geddes | D. Rodgers | J. Gal | V. Bondada | D. E. Croall | Charles B. Mashburn | Katherine E Larochelle | Katherine Larochelle | Vimala Bondada
[1] G. Velez,et al. Structural Insights into the Unique Activation Mechanisms of a Non-classical Calpain and Its Disease-Causing Variants , 2020, Cell reports.
[2] M. Baudry. Calpain-1 and Calpain-2 in the Brain: Dr. Jekill and Mr Hyde? , 2019, Current neuropharmacology.
[3] Danny W. Wilson,et al. Tripeptide analogues of MG132 as protease inhibitors. , 2019, Bioorganic & medicinal chemistry.
[4] R. Campbell,et al. Insertion sequence 1 from calpain-3 is functional in calpain-2 as an internal propeptide , 2018, The Journal of Biological Chemistry.
[5] L. Kaderali,et al. Hepatitis C virus enters liver cells using the CD81 receptor complex proteins calpain-5 and CBLB , 2018, PLoS pathogens.
[6] A. Morris,et al. Capn5 Expression in the Healthy and Regenerating Zebrafish Retina , 2018, bioRxiv.
[7] R. Campbell,et al. Structures of human calpain-3 protease core with and without bound inhibitor reveal mechanisms of calpain activation , 2018, The Journal of Biological Chemistry.
[8] A. Geitmann,et al. A mechanosensitive Ca2+ channel activity is dependent on the developmental regulator DEK1 , 2017, Nature Communications.
[9] J. Wiśniewski,et al. Quantitative Analysis of Human Red Blood Cell Proteome. , 2017, Journal of proteome research.
[10] G. Velez,et al. Small-angle X-ray scattering of calpain-5 reveals a highly open conformation among calpains. , 2016, Journal of structural biology.
[11] Daniel G. MacArthur,et al. The ExAC browser: displaying reference data information from over 60 000 exomes , 2016, bioRxiv.
[12] Ricardo A. Mata,et al. The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design , 2016, Science.
[13] R. Campbell,et al. Rational Design of Calpain Inhibitors Based on Calpastatin Peptidomimetics. , 2016, Journal of medicinal chemistry.
[14] G. Velez,et al. Calpain-5 Expression in the Retina Localizes to Photoreceptor Synapses , 2016, Investigative ophthalmology & visual science.
[15] J. Wiśniewski,et al. In-depth quantitative analysis and comparison of the human hepatocyte and hepatoma cell line HepG2 proteomes. , 2016, Journal of proteomics.
[16] H. Sorimachi,et al. An eccentric calpain, CAPN3/p94/calpain-3. , 2016, Biochimie.
[17] Masanori Watanabe,et al. The second C2‐domain of copine‐2, copine‐6 and copine‐7 is responsible for their calcium‐dependent membrane association , 2015, The FEBS journal.
[18] J. Whisstock,et al. Structural Basis for Ca2+-mediated Interaction of the Perforin C2 Domain with Lipid Membranes* , 2015, The Journal of Biological Chemistry.
[19] Michael J E Sternberg,et al. The Phyre2 web portal for protein modeling, prediction and analysis , 2015, Nature Protocols.
[20] A. Bassuk,et al. Structural Modeling of a Novel CAPN5 Mutation that Causes Uveitis and Neovascular Retinal Detachment , 2015, PloS one.
[21] R. Campbell,et al. Allosteric inhibitors of calpains: Reevaluating inhibition by PD150606 and LSEAL. , 2014, Biochimica et biophysica acta.
[22] J. Bacardit,et al. The eukaryotic N-end rule pathway: conserved mechanisms and diverse functions. , 2014, Trends in cell biology.
[23] S. Corbalán-García,et al. Signaling through C2 domains: more than one lipid target. , 2014, Biochimica et biophysica acta.
[24] Ranjana Singh,et al. Calpain 5 Is Highly Expressed in the Central Nervous System (CNS), Carries Dual Nuclear Localization Signals, and Is Associated with Nuclear Promyelocytic Leukemia Protein Bodies* , 2014, The Journal of Biological Chemistry.
[25] Katherine J. Wert,et al. Functional validation of a human CAPN5 exome variant by lentiviral transduction into mouse retina. , 2014, Human molecular genetics.
[26] R. Campbell,et al. Structure-function relationships in calpains. , 2012, The Biochemical journal.
[27] V. Sheffield,et al. Calpain-5 Mutations Cause Autoimmune Uveitis, Retinal Neovascularization, and Photoreceptor Degeneration , 2012, PLoS genetics.
[28] Jian Peng,et al. Template-based protein structure modeling using the RaptorX web server , 2012, Nature Protocols.
[29] H. Sorimachi,et al. Regulation and physiological roles of the calpain system in muscular disorders , 2012, Cardiovascular research.
[30] A. Varshavsky. The N‐end rule pathway and regulation by proteolysis , 2011, Protein science : a publication of the Protein Society.
[31] L. Aravind,et al. Identification of novel families and classification of the C2 domain superfamily elucidate the origin and evolution of membrane targeting activities in eukaryotes. , 2010, Gene.
[32] M. Maki,et al. Autolytic activity of human calpain 7 is enhanced by ESCRT‐III‐related protein IST1 through MIT–MIM interaction , 2010, The FEBS journal.
[33] Alan Wells,et al. m-calpain Activation Is Regulated by Its Membrane Localization and by Its Binding to Phosphatidylinositol 4,5-Bisphosphate* , 2010, The Journal of Biological Chemistry.
[34] R. Hayes,et al. Multiple alphaII-spectrin breakdown products distinguish calpain and caspase dominated necrotic and apoptotic cell death pathways , 2009, Apoptosis.
[35] Geoffrey J. Barton,et al. Jalview Version 2—a multiple sequence alignment editor and analysis workbench , 2009, Bioinform..
[36] Kalle Gehring,et al. Concerted multi-pronged attack by calpastatin to occlude the catalytic cleft of heterodimeric calpains , 2008, Nature.
[37] R. Campbell,et al. Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin , 2008, Nature.
[38] C. Faulkner,et al. The Phytocalpain Defective Kernel 1 Is a Novel Arabidopsis Growth Regulator Whose Activity Is Regulated by Proteolytic Processing[W] , 2008, The Plant Cell Online.
[39] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[40] K. Ersfeld,et al. The calpains: modular designs and functional diversity , 2007, Genome Biology.
[41] A. Chishti,et al. Calpain-mediated regulation of platelet signaling pathways , 2007, Current opinion in hematology.
[42] T. Südhof,et al. E-Syts, a family of membranous Ca2+-sensor proteins with multiple C2 domains , 2007, Proceedings of the National Academy of Sciences.
[43] G. Basso,et al. Bortezomib-mediated 26S proteasome inhibition causes cell-cycle arrest and induces apoptosis in CD-30+ anaplastic large cell lymphoma , 2007, Leukemia.
[44] F. Fiorino,et al. A new cell‐permeable calpain inhibitor , 2007, Journal of peptide science : an official publication of the European Peptide Society.
[45] K. Brandenburg,et al. Investigations into the membrane interactions of m-calpain domain V. , 2005, Biophysical journal.
[46] T. Südhof,et al. Evolutionarily Conserved Multiple C2 Domain Proteins with Two Transmembrane Regions (MCTPs) and Unusual Ca2+ Binding Properties* , 2005, Journal of Biological Chemistry.
[47] R. Hayes,et al. Molecular cloning and characterization of rat and human calpain-5. , 2004, Biochemical and biophysical research communications.
[48] T. Südhof,et al. C2-Domains in Ca2+-Signaling , 2003 .
[49] A. Rao,et al. The Calpain Domain of the Maize DEK1 Protein Contains the Conserved Catalytic Triad and Functions as a Cysteine Proteinase* , 2003, Journal of Biological Chemistry.
[50] D. E. Goll,et al. The calpain system. , 2003, Physiological reviews.
[51] Z. Jia,et al. Calpain silencing by a reversible intrinsic mechanism , 2003, Nature Structural Biology.
[52] S. Bolsover,et al. Role of the Ca2+/Phosphatidylserine Binding Region of the C2 Domain in the Translocation of Protein Kinase Cα to the Plasma Membrane* , 2003, The Journal of Biological Chemistry.
[53] Joseph J. Falke,et al. C2 Domains of Protein Kinase C Isoforms α, β, and γ: Activation Parameters and Calcium Stoichiometries of the Membrane-Bound State , 2002 .
[54] P. Tompa,et al. Calpastatin Subdomains A and C Are Activators of Calpain* , 2002, The Journal of Biological Chemistry.
[55] Z. Jia,et al. A Ca2+ Switch Aligns the Active Site of Calpain , 2002, Cell.
[56] T. Südhof,et al. Three-Dimensional Structure of the Synaptotagmin 1 C2B-Domain Synaptotagmin 1 as a Phospholipid Binding Machine , 2001, Neuron.
[57] N. Verdaguer,et al. Structure of the C2 domain from novel protein kinase Cepsilon. A membrane binding model for Ca(2+)-independent C2 domains. , 2001, Journal of molecular biology.
[58] K. Suzuki,et al. Domain III of calpain is a ca2+-regulated phospholipid-binding domain. , 2001, Biochemical and biophysical research communications.
[59] Kevin K. W Wang,et al. Calpain and caspase: can you tell the difference? , 2000, Trends in Neurosciences.
[60] D. Potter,et al. Inhibition of Calpain Blocks Platelet Secretion, Aggregation, and Spreading* , 1999, The Journal of Biological Chemistry.
[61] M. Nakao,et al. Calcium influx triggers the sequential proteolysis of extracellular and cytoplasmic domains of E-cadherin, leading to loss of β-catenin from cell – cell contacts , 1999, Oncogene.
[62] N. Verdaguer,et al. Ca2+ bridges the C2 membrane‐binding domain of protein kinase Cα directly to phosphatidylserine , 1999 .
[63] Tomohiko Maehama,et al. Crystal Structure of the PTEN Tumor Suppressor Implications for Its Phosphoinositide Phosphatase Activity and Membrane Association , 1999, Cell.
[64] S. Corbalán-García,et al. Determination of the calcium-binding sites of the C2 domain of protein kinase Calpha that are critical for its translocation to the plasma membrane. , 1999, The Biochemical journal.
[65] M. Medkova,et al. Mutagenesis of the C2 Domain of Protein Kinase C-α , 1998, The Journal of Biological Chemistry.
[66] T. Südhof,et al. C2-domains, Structure and Function of a Universal Ca2+-binding Domain* , 1998, The Journal of Biological Chemistry.
[67] H. Saya,et al. Identification of a novel, tissue-specific calpain htra-3; a human homologue of the Caenorhabditis elegans sex determination gene. , 1997, Biochemical and biophysical research communications.
[68] M. Vingron,et al. A new subfamily of vertebrate calpains lacking a calmodulin-like domain: implications for calpain regulation and evolution. , 1997, Genomics.
[69] T. Südhof,et al. The Evolutionary Pressure to Inactivate , 1997, The Journal of Biological Chemistry.
[70] R. Nixon,et al. Calpains and calpastatin in SH‐SY5Y neuroblastoma cells during retinoic acid‐induced differentiation and neurite outgrowth: Comparison with the human brain calpain system , 1997, Journal of neuroscience research.
[71] E. Carafoli,et al. Calpain: A Cytosolic Proteinase Active at the Membranes , 1997, The Journal of Membrane Biology.
[72] J. Falke,et al. The C2 domain calcium‐binding motif: Structural and functional diversity , 1996, Protein science : a publication of the Protein Society.
[73] P. Tompa,et al. Autolysis parallels activation of mu-calpain. , 1996, The Biochemical journal.
[74] K. Wang,et al. Maitotoxin induces calpain activation in SH-SY5Y neuroblastoma cells and cerebrocortical cultures. , 1996, Archives of biochemistry and biophysics.
[75] Hisashi Ito,et al. Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. , 1996, Journal of biochemistry.
[76] A. Newton,et al. Protein Kinase C: Structure, Function, and Regulation (*) , 1995, The Journal of Biological Chemistry.
[77] J. Fox. The Platelet Cytoskeleton , 1993, Thrombosis and Haemostasis.
[78] N. Brown,et al. Structural modifications associated with the change in Ca2+ sensitivity on activation of m‐calpain , 1993, FEBS letters.
[79] T. Zalewska,et al. Is calpain activity regulated by membranes and autolysis or by calcium and calpastatin? , 1992, BioEssays : news and reviews in molecular, cellular and developmental biology.
[80] C. Slaughter,et al. Polyclonal antisera specific for the proenzyme form of each calpain. , 1992, Biochimica et biophysica acta.
[81] G. Demartino,et al. Calcium-activated neutral protease (calpain) system: structure, function, and regulation. , 1991, Physiological reviews.
[82] E. Melloni,et al. The calpains , 1989, Trends in Neurosciences.
[83] M. Maki,et al. Inhibition of calpain by a synthetic oligopeptide corresponding to an exon of the human calpastatin gene. , 1989, The Journal of biological chemistry.
[84] D. E. Goll,et al. The role of autolysis in activity of the Ca2+-dependent proteinases (mu-calpain and m-calpain). , 1989, The Journal of biological chemistry.
[85] H. Kawasaki,et al. Calcium‐activated neutral protease and its endogenous inhibitor Activation at the cell membrane and biological function , 1987, FEBS letters.
[86] B. Horecker,et al. Role of phospholipids in the activation of the Ca2+-dependent neutral proteinase of human erythrocytes. , 1985, Biochemical and biophysical research communications.
[87] D. Croall,et al. Comparison of two calcium-dependent proteinases from bovine heart. , 1984, Biochimica et biophysica acta.
[88] Y. Ohizumi,et al. Contraction and increase in tissue calcium content induced by maitotoxin, the most potent known marine toxin, in intestinal smooth muscle , 1983, British journal of pharmacology.
[89] K. Imahori,et al. Autolysis of calcium-activated neutral protease of chicken skeletal muscle. , 1981, Journal of biochemistry.
[90] K. Imahori,et al. Limited autolysis of Ca2+-activated neutral protease (CANP) changes its sensitivity to Ca2+ ions. , 1981, Journal of biochemistry.
[91] L S Freedman,et al. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. , 1978, Cancer research.
[92] E. Krebs,et al. Activation of skeletal muscle phosphorylase kinase by Ca2+. II. Identification of the kinase activating factor as a proteolytic enzyme. , 1968, Biochemistry.
[93] R. Hayes,et al. Potential Use of Calpain Inhibitors as Brain Injury Therapy , 2015 .
[94] H. Sorimachi,et al. Calpains: an elaborate proteolytic system. , 2012, Biochimica et biophysica acta.
[95] I. Assfalg-Machleidt,et al. μ-Calpain binds to lipid bilayers via the exposed hydrophobic surface of its Ca2+-activated conformation , 2006 .
[96] Barry Honig,et al. Electrostatic control of the membrane targeting of C2 domains. , 2002, Molecular cell.
[97] A. Goldberg,et al. Proteasome inhibitors: from research tools to drug candidates. , 2001, Chemistry & biology.
[98] Elizabeth M. Smigielski,et al. dbSNP: a database of single nucleotide polymorphisms , 2000, Nucleic Acids Res..
[99] G. Guroff,et al. A NEUTRAL, CALCIUM-ACTIVATED PROTEINASE FROM THE SOLUBLE FRACTION OF RAT BRAIN. , 1964, The Journal of biological chemistry.